{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:50:58Z","timestamp":1793411458623,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.canlet.2025.217444","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T02:31:56Z","timestamp":1736130716000},"page":"217444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model"],"prefix":"10.1016","volume":"611","author":[{"given":"Ujjwol","family":"Khatri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriya","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj K.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Subbiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2864-1606","authenticated-orcid":false,"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217444_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ccell.2023.02.007","article-title":"Cancer cachexia: involvement of an expanding macroenvironment","volume":"41","author":"Pryce","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217444_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217444_bib3","article-title":"Advances in cancer cachexia: intersection between affected organs, mediators, and pharmacological interventions","volume":"1873","author":"Siddiqui","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.217444_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41591-023-02232-8","article-title":"Body composition and lung cancer-associated cachexia in TRACERx","volume":"29","author":"Al-Sawaf","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","article-title":"The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217444_bib6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1078-0432.CCR-23-1631","article-title":"A phase Ib first-in-patient study assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of ponsegromab in participants with cancer and cachexia","volume":"30","author":"Crawford","year":"2024","journal-title":"Clin. Cancer Res. : An Off. J. American Assoc. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217444_bib8","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib10","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217444_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3892\/ol.2023.14049","article-title":"Role of growth differentiation factor 15 in cancer cachexia (Review)","volume":"26","author":"Ling","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2025.217444_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111947","article-title":"GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia","volume":"42","author":"Kim-Muller","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217444_bib15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.trecan.2021.07.003","article-title":"Precision therapy for RET-altered cancers with RET inhibitors","volume":"7","author":"Thein","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2025.217444_bib16","article-title":"Exceptional responses to selpercatinib in RET fusion-driven metastatic pancreatic cancer","volume":"7","author":"Bhamidipati","year":"2023","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.canlet.2025.217444_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.annonc.2023.07.002","article-title":"Weight gain in patients with RET aberrant cancers treated with brain penetrant RET selective inhibitors","volume":"34","author":"Gouda","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2025.217444_bib18","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/bph.14395","article-title":"Drug resistance profiles of mutations in the RET kinase domain","volume":"175","author":"Liu","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217444_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.annonc.2020.10.599","article-title":"Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations","volume":"32","author":"Subbiah","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2025.217444_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100958","article-title":"The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1\/2-driven Aurora A\/B kinases","volume":"68","author":"Hu","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2025.217444_bib21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-020-01343-7","article-title":"Selpercatinib: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.canlet.2025.217444_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41698-021-00188-x","article-title":"The L730V\/I RET roof mutations display different activities toward pralsetinib and selpercatinib","volume":"5","author":"Shen","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2025.217444_bib23","first-page":"57026","article-title":"Mouse adipose tissue collection and processing for RNA analysis","volume":"131","author":"Tan","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.canlet.2025.217444_bib24","first-page":"54893","article-title":"The colon-26 carcinoma tumor-bearing mouse as a model for the study of cancer cachexia","volume":"117","author":"Bonetto","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.canlet.2025.217444_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103281","article-title":"Protocol for establishing and evaluating a cancer cachexia mouse model","volume":"5","author":"Zhou","year":"2024","journal-title":"STAR Protoc"},{"key":"10.1016\/j.canlet.2025.217444_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217444_bib27","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2025.217444_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.canlet.2025.217444_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1158\/1535-7163.MCT-22-0629","article-title":"Targeting RET solvent-front mutants with alkynyl nicotinamide-based inhibitors","volume":"22","author":"Khatri","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.217444_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217444_bib31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2005653","article-title":"Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer","volume":"383","author":"Drilon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib32","series-title":"Selpercatinib in Patients with RET Fusion-Positive Non-small-cell Lung Cancer: Updated Safety and Efficacy from the Registrational LIBRETTO-001 Phase I\/II Trial","author":"Drilon","year":"2022"},{"key":"10.1016\/j.canlet.2025.217444_bib33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S1470-2045(22)00541-1","article-title":"Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1\/2, open-label, basket trial","volume":"23","author":"Subbiah","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canlet.2025.217444_bib34","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/jcsm.12618","article-title":"Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model","volume":"11","author":"Bernardo","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.canlet.2025.217444_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309394","article-title":"Neutralizing antibody against GDF15 for treatment of cancer-associated cachexia","volume":"19","author":"Xiong","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217444_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217444_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","article-title":"Quantitative proteomics of the cancer cell line Encyclopedia","volume":"180","author":"Nusinow","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217444_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217444_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113960","article-title":"Activation of GFRAL(+) neurons induces hypothermia and glucoregulatory responses associated with nausea and torpor","volume":"43","author":"Engstrom Ruud","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217444_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9592","article-title":"Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia","volume":"13","author":"Sartori","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186663","article-title":"MuRF1\/TRIM63, master regulator of muscle mass","volume":"21","author":"Peris-Moreno","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217444_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semcancer.2016.01.002","article-title":"F-BOX proteins in cancer cachexia and muscle wasting: emerging regulators and therapeutic opportunities","volume":"36","author":"Sukari","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217444_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00170-4","article-title":"ULK1 promotes mitophagy via phosphorylation and stabilization of BNIP3","volume":"11","author":"Poole","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217444_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216590","article-title":"Natural compounds modulating mitophagy: implications for cancer therapy","volume":"582","author":"Cao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217444_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217444_bib46","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2025.217444_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217285","article-title":"Autophagy and cancer therapy","volume":"605","author":"Pimentel","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217444_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216662","article-title":"The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics","volume":"585","author":"Biswas","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217444_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216307","article-title":"Autophagy and cancer drug resistance in dialogue: pre-clinical and clinical evidence","volume":"570","author":"Qin","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217444_bib50","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1101\/gad.912401","article-title":"Hierarchical phosphorylation of the translation inhibitor 4E-BP1","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.217444_bib51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2007.11.004","article-title":"FoxO3 coordinately activates protein degradation by the autophagic\/lysosomal and proteasomal pathways in atrophying muscle cells","volume":"6","author":"Zhao","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2025.217444_bib52","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.biocel.2005.04.018","article-title":"Skeletal muscle hypertrophy and atrophy signaling pathways","volume":"37","author":"Glass","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217444_bib53","article-title":"CHAC1 inactivation is effective to preserve muscle glutathione but is insufficient to protect against muscle wasting in cachexia","volume":"18","author":"Li","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217444_bib54","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1038\/s41467-023-40595-1","article-title":"REPTOR and CREBRF encode key regulators of muscle energy metabolism","volume":"14","author":"Saavedra","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217444_bib55","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1111\/bph.15625","article-title":"Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice","volume":"178","author":"Niu","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217444_bib56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41467-021-27865-6","article-title":"MyoD is a 3D genome structure organizer for muscle cell identity","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217444_bib57","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1073\/pnas.0703918105","article-title":"The myocardin-related transcription factor, MASTR, cooperates with MyoD to activate skeletal muscle gene expression","volume":"105","author":"Meadows","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2025.217444_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","article-title":"GDF15 promotes weight loss by enhancing energy expenditure in muscle","volume":"619","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217444_bib59","doi-asserted-by":"crossref","first-page":"373","DOI":"10.21873\/cdp.10119","article-title":"Body weight change in non-small cell lung cancer patients treated with EGFR-TKI","volume":"2","author":"Kodama","year":"2022","journal-title":"Cancer Diagn Progn"},{"key":"10.1016\/j.canlet.2025.217444_bib60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jtho.2023.03.020","article-title":"Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer","volume":"18","author":"de Leeuw","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2025.217444_bib61","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1158\/1535-7163.MCT-14-0274","article-title":"Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer","volume":"13","author":"Kodama","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.217444_bib62","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jtho.2016.08.126","article-title":"Clinical activity of alectinib in advanced RET-rearranged non-small cell lung cancer","volume":"11","author":"Lin","year":"2016","journal-title":"J. Thorac. Oncol. : Off. Pub. Int. Assoc. Study Lung Cancer"},{"key":"10.1016\/j.canlet.2025.217444_bib63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00360-024-01554-4","article-title":"Methods to estimate body temperature and energy expenditure dynamics in fed and fasted laboratory mice: effects of sleep deprivation and light exposure","volume":"194","author":"van der Vinne","year":"2024","journal-title":"J. Comp. Physiol. B"},{"key":"10.1016\/j.canlet.2025.217444_bib64","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa2309457","article-title":"First-line selpercatinib or chemotherapy and pembrolizumab in RET fusion-positive NSCLC","volume":"389","author":"Zhou","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib65","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa2309719","article-title":"Phase 3 trial of selpercatinib in advanced RET-mutant medullary thyroid cancer","volume":"389","author":"Hadoux","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217444_bib66","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:55:47Z","timestamp":1760741747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":66,"alternative-id":["S0304383525000084"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217444","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217444"}}